Literature DB >> 1886716

Normal c-abl gene protein--a nuclear component.

S Dhut1, T Chaplin, B D Young.   

Abstract

The subcellular distribution of the c-abl and bcr-abl gene products from KG1A and K562 cells has been studied by two different techniques. Firstly, physical disruption followed by subcellular fractionation was used to demonstrate that normal c-abl (p145) was recovered from the cytosol and the nuclear fractions of KG1A cells. In contrast, bcr-abl products were recovered exclusively from the cytosol fraction of K562 cells. Secondly, indirect immunofluorescence was used to localize c-abl protein to the cytoplasm, nuclear membrane and infrequently to the nucleus of KG1A cells and bcr-abl protein to only the cytoplasm of K562 cells. Thus both the approaches indicate that there is a component of normal c-abl products which appears to be nuclear and this is not reflected in the distribution of the bcr-abl 210 kDa protein, which remains cytosolic.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1886716

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Multiple cDNAs encoding the esk kinase predict transmembrane and intracellular enzyme isoforms.

Authors:  E M Douville; D E Afar; B W Howell; K Letwin; L Tannock; Y Ben-David; T Pawson; J C Bell
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

2.  Retroviral vector design for gene therapy of cancer: specific inhibition and tagging of BCR-ABLp190 cells.

Authors:  B García-Hernández; I Sánchez-García
Journal:  Mol Med       Date:  1996-01       Impact factor: 6.354

3.  En bloc substitution of the Src homology region 2 domain activates the transforming potential of the c-Abl protein tyrosine kinase.

Authors:  A J Muller; A M Pendergast; K Parmar; M H Havlik; N Rosenberg; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

4.  Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.

Authors:  M Wetzler; M Talpaz; R A Van Etten; C Hirsh-Ginsberg; M Beran; R Kurzrock
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

5.  Subcellular localization of a protein-tyrosine phosphatase: evidence for association with chromatin.

Authors:  V Radha; S Nambirajan; G Swarup
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

6.  Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2.

Authors:  I Sánchez-García; G Grütz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

7.  Hormone-conditional transformation by fusion proteins of c-Abl and its transforming variants.

Authors:  P Jackson; D Baltimore; D Picard
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

8.  Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway.

Authors:  L Puil; J Liu; G Gish; G Mbamalu; D Bowtell; P G Pelicci; R Arlinghaus; T Pawson
Journal:  EMBO J       Date:  1994-02-15       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.